IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MITOLA, STEFANIA MARIA FILOMENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.514
EU - Europa 8.794
AS - Asia 4.956
SA - Sud America 902
AF - Africa 94
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
Totale 24.292
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.379
PL - Polonia 5.073
CN - Cina 1.693
SG - Singapore 1.512
IT - Italia 865
UA - Ucraina 822
BR - Brasile 770
DE - Germania 581
HK - Hong Kong 540
VN - Vietnam 480
FI - Finlandia 324
GB - Regno Unito 282
TR - Turchia 176
RU - Federazione Russa 166
IE - Irlanda 154
IN - India 149
FR - Francia 114
ID - Indonesia 97
ES - Italia 72
SE - Svezia 71
BD - Bangladesh 64
CA - Canada 63
AR - Argentina 57
NL - Olanda 50
BE - Belgio 48
CZ - Repubblica Ceca 45
MX - Messico 45
ZA - Sudafrica 45
JP - Giappone 39
AT - Austria 28
IQ - Iraq 26
EC - Ecuador 21
AU - Australia 20
MA - Marocco 17
UZ - Uzbekistan 16
IR - Iran 15
AE - Emirati Arabi Uniti 14
PK - Pakistan 14
VE - Venezuela 14
CH - Svizzera 13
SA - Arabia Saudita 12
GR - Grecia 11
IL - Israele 11
AZ - Azerbaigian 10
CL - Cile 10
KE - Kenya 10
CO - Colombia 9
EE - Estonia 9
PH - Filippine 9
PY - Paraguay 9
EG - Egitto 8
KG - Kirghizistan 8
KR - Corea 8
MY - Malesia 8
NO - Norvegia 8
EU - Europa 7
JO - Giordania 7
AL - Albania 6
BG - Bulgaria 6
DZ - Algeria 6
KZ - Kazakistan 6
LK - Sri Lanka 6
LT - Lituania 6
PA - Panama 6
DK - Danimarca 5
HU - Ungheria 5
NZ - Nuova Zelanda 5
OM - Oman 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
JM - Giamaica 4
LA - Repubblica Popolare Democratica del Laos 4
NP - Nepal 4
PE - Perù 4
AM - Armenia 3
BO - Bolivia 3
BY - Bielorussia 3
HN - Honduras 3
HR - Croazia 3
LV - Lettonia 3
PT - Portogallo 3
TN - Tunisia 3
CR - Costa Rica 2
ET - Etiopia 2
LB - Libano 2
MD - Moldavia 2
PS - Palestinian Territory 2
SV - El Salvador 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
Totale 24.278
Salva come PNG Salva come JPEG
Città #
Warsaw 5.068
Fairfield 1.086
Ashburn 882
Woodbridge 719
Singapore 707
Houston 684
Jacksonville 610
Hong Kong 536
Ann Arbor 495
Seattle 447
Brescia 444
Cambridge 419
Chandler 385
Wilmington 363
Beijing 356
Princeton 279
Dong Ket 241
New York 224
Nanjing 199
Dearborn 198
Los Angeles 187
Helsinki 155
Dublin 149
Istanbul 139
Dallas 127
Munich 116
Milan 93
The Dalles 88
Ho Chi Minh City 84
São Paulo 82
Jakarta 81
Nanchang 77
Shanghai 77
Buffalo 76
Des Moines 74
Jinan 70
San Francisco 68
Shenyang 65
Changsha 62
Turku 60
Hebei 59
Chicago 56
Moscow 54
Phoenix 54
Madrid 50
Hanoi 49
San Diego 48
Brussels 46
Redondo Beach 45
Hangzhou 43
London 43
Santa Clara 39
Jiaxing 36
Boardman 34
Tianjin 34
Brooklyn 31
Guangzhou 31
Kunming 30
Stockholm 30
Tokyo 30
Johannesburg 29
Zhengzhou 28
Haikou 27
Lancaster 25
Nuremberg 24
Rio de Janeiro 24
Washington 23
Denver 22
Ningbo 22
Amsterdam 20
Atlanta 20
Brno 20
Orem 20
Rome 19
San Mateo 19
Lappeenranta 18
Montreal 18
Olomouc 18
Toronto 18
Belo Horizonte 17
Dhaka 17
Poplar 17
Ankara 16
Boston 16
Curitiba 16
Mexico City 16
Verona 16
Augusta 15
Charlotte 15
Chennai 15
Hefei 15
Lanzhou 15
Taizhou 15
Tashkent 14
Brasília 13
Council Bluffs 12
Kilburn 12
Leawood 12
Monmouth Junction 12
Orange 12
Totale 17.836
Salva come PNG Salva come JPEG
Nome #
Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. 381
Annexin 2A sustains glioblastoma cell dissemination and proliferation. 351
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 299
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 298
Multi-physics interactions drive VEGFR2 relocation on endothelial cells. 293
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 289
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 283
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 281
A study on the VEGFR2-ligand multi-physics interactions in Angiogenesis. 274
Tumor angiogenesis revisited: Regulators and clinical implications 274
Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient Mice 273
Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis 273
Claudin3 is localized outside the tight junctions in human carcinomas 272
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 265
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 264
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 263
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 263
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 259
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 258
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 251
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 251
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 248
Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro. 245
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 245
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 241
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 239
Integrins: A flexible platform for endothelial vascular tyrosine kinase receptors. 237
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 237
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 234
Regulation of dendritic cell migration and adaptive immune response by leukotriene b4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function 233
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 233
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells. 229
Involvement of chemokine receptor4/ cell-derived factor 1 system during osteosarcoma tumor progression 226
Interactions between endothelial cells and HIV-1. 222
Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. 220
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 220
Nitric oxide modulates the angiogenic phenotype of middle-T transformed endothelial cells. 219
Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. 219
Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. 217
IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. 217
Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1. 216
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 210
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 209
Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells. 208
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 205
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 203
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 202
Preliminary observations on scleral ossicles in performing functionalized 3D vascularized scaffolds for “critical-size” bone defect healing 198
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 197
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 197
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 192
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivative.Effect on the motility of vascular endothelial cells. 190
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 188
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 183
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 183
Silencing of pantothenate kinase 2 reduces endothelial cell angiogenesis 181
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 180
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 180
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 178
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 172
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 170
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 168
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 161
A Model of Integrin and VEGF Receptors Recruitment on Endothelial Cells 161
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 158
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 154
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 151
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 148
Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process 148
Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology. 145
Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. 144
The Ferritin-Heavy-Polypeptide-Like-17 (FTHL17) gene encodes a ferritin with low stability and no ferroxidase activity and with a partial nuclear localization 143
Insights on the receptor dynamics during the spreading of endothelial cells 142
IL-12 regulates an endothelial cell-lymphocyte network: effect on metalloproteinase-9 production. 139
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 139
Evaluation of Paracellular Permeability in VEGFR2 Mutants Patient-Derived Organoid 138
Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production. 133
Co-designed experiments and multi-physics modeling of the VEGFR-2 relocation on endothelial cells. 133
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 133
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 132
CCL16 activates an angiogenic program in vascular endothelial cells 131
Vascular disrupting activity of combretastatin analogues 130
Gremlin as a novel pro-angiogenic VEGFR2 agonist: production of a biologically active recombinant form in S2 Drosophila cells 128
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 126
Simulation of VEGF receptor recruitment on ECs membrane 126
Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels 125
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. 125
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 124
Role of VEGFs in metabolic disorders 124
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 124
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 123
Fibroblast growth factor-2 in angiogenesis 122
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 122
Dendritic cell-endothelial cell cross-talk in angiogenesis. 120
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 120
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 118
A mechano-biological model of the coupling between cellular con- tractility and VEGFR2/VEGF interactions. 118
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 118
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 116
Inhibition of vascular endothelial growth factor receptor 2 - mediated endothelial cell activation by Axl tyrosine kinase receptor. 115
Totale 19.563
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.381
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.131 0 0 0 0 0 343 190 342 366 302 274 314
2021/20221.291 81 244 27 28 37 69 74 72 67 176 103 313
2022/20231.191 198 78 61 69 90 276 22 103 166 15 42 71
2023/20241.607 85 71 154 124 91 243 60 101 295 119 40 224
2024/20253.248 69 25 38 485 363 252 291 141 394 200 572 418
2025/20263.862 650 851 527 1.002 759 73 0 0 0 0 0 0
Totale 24.661